Market intelligence - Page 1Stay up to date with the latest Market intelligence updates from the global world pharmaceuticals industry
Latest Market intelligence Update
Over 225 procurement processionals are expected at Europe’s only event...
> read more
Evonik and Lilly renew long-term supply agreement
Evonik Industries and Eli Lilly and Company (Lilly) have announced the renewal of a long-term agreement under which Evonik will supply active pharmaceutical ingredients (APIs)...
RAI Amsterdam to host CTS and PCT Europe
RAI Amsterdam Convention Centre is the venue for Clinical Trial Supply 2017 and Partnerships in Clinical Trials Europe.
LogiPharma, the largest global end-to-end supply chain event for pharma supply chain leaders, their teams and service partners, will take place at the Montreux Music & Convention...
Insmed announces worldwide license agreement with AstraZeneca for Oral DPP1 inhibitor
Insmed expects to advance compound into a phase 2 dose-ranging study in non-cystic fibrosis bronchiectasis in 2017.
Körber AG plans to acquire Fargo Automation
International technology group Körber, headquartered in Hamburg, Germany, is planning to acquire the company Fargo Automation, Inc., based in Fargo, North Dakota, US.
Roquette goes EXCiPACT to serve its pharmaceuticals customers
Roquette, one of the world's leading excipients manufacturers, is announcing a significant step forward in serving its customers with the award of the EXCiPACT™ certification.
LogiPharma is the largest global end-to-end supply chain event for pharma supply chain leaders, their teams and service partners.
UK leads Europe in antimicrobial point-of-care diagnostics research
The UK takes the lead position when it comes to patent filings for point-of-care diagnostics in Europe, according to new research.
Alizé Pharma to present clinical results from the AZP-531 programme
Alizé Pharma SAS, an Alizé Pharma group company specialised in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, will present the results from...
Antares Vision announces 100th ATS 3.0 Track and Trace System installation
Antares Vision, a leading supplier of inspection and serialisation systems for the pharmaceutical industry, reports the installation of its 100th ATS 3.0 Plant Manager.
Herbert C. Buchanan Jr joins Noxilizer board of directors
Noxilizer to leverage Buchanan's leadership and healthcare expertise to drive market growth and expansion.
Biotec Services International completes rebrand to PCI Group
Biotec Services International has rebranded as part of the PCI group, expanding PCI’s capability to deliver an integrated pharmaceutical service for global studies of...
Branded drug prices soar 15% in the US
Consumers in the US saw branded drug prices rise by 14.8% last year, according to Truveris, a leading platform for prescription drug pricing and benefits analysis. In turn,...
G7 AMD drug market to approach $9 billion by 2023
Sales of drugs to treat age-related macular degeneration in the G7 pharmaceutical markets are set to grow 6% a year, reaching nearly $9 billion in 2023.
NHS spends 10% of drugs budget on diabetes
Nearly 10% of the National Health Service’s drugs expenditure is now on managing diabetes. Seven out of ten prescriptions in 2013-14 were for type 2 diabetes medication, which is...
Roche acquires Seragon Pharmaceuticals for $725 million
Swiss giant Roche is to pay $725 million to acquire breast cancer specialist Seragon Pharmaceuticals.
Novartis refocuses global portfolio
Novartis has reached a definitive agreement with GlaxoSmithKline plc (GSK) to exchange certain assets, building global leadership in key segments and focusing the company's portfolio.
UDG Healthcare acquires market-leading healthcare communications provider
UDG Healthcare plc, a leading international provider of healthcare services, has agreed to acquire the healthcare communications business of KnowledgePoint360.
Novartis drug Lucentis approved by Japanese regulatory bodies
Lucentis® (ranibizumab) has been approved by Japanese regulatory bodies for a fourth indication: the treatment of patients with diabetic macular edema (DME), a leading cause of...